The IFOM-IEO Campus
photo ©:Grazia Neri [+zoom]
Some numbers for the new Campus:
- 24.000 m2 campus surface area
- 12.000 m2 of laboratories
- 600 research work stations
- 450 scientists
- 38 research groups
- 11 technological units
The IFOM-IEO Campus is a new biomedical research centre, created by the joint efforts of the FIRC Institute of Molecular Oncology Foundation (IFOM) and the Department of Experimental Oncology of the European Institute of Oncology (IEO), which have expanded and integrated their research activities on a common campus.
The IFOM-IEO Campus is located in Milan, the heart of the commercial/industrial north of Italy, where it benefits from numerous interactions with other scientific and medical organizations in the area . The Campus is also home to the Ph.D programs of the European School of Molecular Medicine (SEMM), which it is running in collaboration with the University of Milan, the University of Naples "Federico II" and the Italian Institute of Technology (IIT) in Genoa.
The scientific revolution that has taken place in biology and medicine since the completion of the Human Genome Project, marks the beginning of a new era in the conception and implementation of medicine. Managing the transition to "post-genomic" science requires new programs and structures to foster the simultaneous development of basic science, advanced technologies, information transfer and clinical research as well as internal and external collaborations.
Scientist at the Campus IFOM-IEO photo ©: Sestini
For this reason, the mission of the IFOM-IEO Campus is the development and application of genomics to research in basic and translational oncology. Our ultimate aim is to achieve a rapid transfer of the emerging concepts in the etiology and development of cancer to new strategies of treatment and prevention.
A critical mass of outstanding scientists that work and collaborate together within the same institute is essential to our mission. This has been one of the main driving forces for establishing the IFOM-IEO Campus.
Research, technology and education
Scientists at the IFOM-IEO Campus are investigating some of the most fundamental questions in cancer research, in fields ranging from molecular and cellular biology, genetics, functional genomics, proteomics, bioinformatics, systems biology and bioethics. An in-depth understanding of the basic biological mechanisms responsible for the initiation and progression of cancer will allow the development of novel and rational strategies for cancer treatment and prevention.
The Campus IFOM-IEO [+zoom] photo ©: Tips
Our research is supported by a core technology facility that offers cutting-edge technologies in nanotechnology (DNA arrays), bioinformatics, robotics, proteomics, structural biology and animal models. This technology core is managed and coordinated by the "Cogentech" consortium.
Alongside our research activities, the IFOM-IEO Campus houses a number of educational and training programs organised by the SEMM: five International, multidisciplinary Ph.D programs and a new International Post-doc program are currently being offered. In addition, the IFOM-IEO Campus hosts a number of international conferences and has an active scientific seminar and lecture program run by the SEMM.
The IFOM-IEO Campus integrates the activities of the following organizations:
- IFOM (The FIRC Institute of Molecular Oncology Foundation), a research institute dedicated to the study of the molecular mechanisms underlying cancer formation and development. IFOM holds a number of agreements with scientific institutions in the area, such as the San Raffaele Biomedical Science Park of Milan, the Istituto Nazionale per lo Studio e la Cura dei Tumori of Milan, the Istituto di Ricerche Farmacologiche Mario Negri, which allow scientists from these institutes to perform innovative research at IFOM. In addition, IFOM sponsors two outstations: one at the University of Genoa and other at the the Institute for Cancer Research and Treatment (IRCC) in Turin.
- IEO The European Institute of Oncology (IEO) is an independent, nonprofit biomedical research institution and one of the 8 Ministry of Health-designated comprehensive cancer centres in Italy. In addition to providing patients with the best care available, IEO is committed to cutting-edge research in oncology, ranging from basic to translational research and clinical trials.
- Università degli studi di Milano The University of Milan holds number of agreements with IFOM and IEO relating to education, research and the development of new therapies for cancer treatment. As a consequence of these agreements, outstanding scientists from the University of Milan have joined in the IFOM-IEO Campus, where they carry out innovative research and participate in its educational programs.
- Cogentech is a consortium promoted by IFOM and IEO that is dedicated to the development of cutting-edge genomic and post-genomic technologies (DNA sequencing, nanotechnology, model organisms, molecular pathology, proteomics, imaging). Cogentech, which collaborates with the Italian Institute of Technology (IIT, Genoa), provides technological services for Campus scientists and for external laboratories.
- SEMM is a private foundation, whose mission is to foster innovative education in the post-genomic field through: international Ph.D. programs in Molecular Medicine, Medical Nanotechnology and and the Foundations and Ethics of Life Sciences; International Post-doc program; International Conferences; scientific seminars.
- Genextra, is a private start-up biotechnology company focused on age-related diseases, cancer and metabolic disorders.
- TTFactor srl is a company entirely owned and controlled by the two institutes IFOM and IEO, incorporated in 2010 for the purposes of advancing scientific results arising from the IFOM and IEO through patenting, technology licensing, sponsored research and spin off creation.